HER2+ breast cancer treatment and cardiotoxicity: monitoring and management Guy JerusalemPatrizio LancellottiSung-Bae Kim Review Open access 05 June 2019 Pages: 237 - 250
A review of the influence of mammographic density on breast cancer clinical and pathological phenotype Michael S. ShawkyCecilia W. HuoErik W. Thompson Review 08 June 2019 Pages: 251 - 276
Breast leptomeningeal disease: a review of current practices and updates on management Nicholas B. FiguraVictoria T. RizkKamran A. Ahmed Review 17 June 2019 Pages: 277 - 294
Quality of DCIS information on the internet: a content analysis Jayden BlackwoodFrances C. WrightAnna R. Gagliardi Review Open access 18 June 2019 Pages: 295 - 305
Indolylkojyl methane analogue IKM5 potentially inhibits invasion of breast cancer cells via attenuation of GRP78 Debasis NayakArchana KatochAnindya Goswami Preclinical study 07 June 2019 Pages: 307 - 323
Somatic loss of PIK3R1 may sensitize breast cancer to inhibitors of the MAPK pathway Sanja B. TurturroMatthew S. NajorMelody A. Cobleigh Preclinical study 17 June 2019 Pages: 325 - 333
Schlafen-11 expression is associated with immune signatures and basal-like phenotype in breast cancer Edoardo IsnaldiDomenico FerraioliGabriele Zoppoli Preclinical study 20 June 2019 Pages: 335 - 343
Triple-negative breast cancer cell line sensitivity to englerin A identifies a new, targetable subtype Corena V. GrantChase M. CarverSusan L. Mooberry Preclinical study 22 June 2019 Pages: 345 - 355
Role of docosahexaenoic acid in enhancement of docetaxel action in patient-derived breast cancer xenografts Marnie NewellSusan GorukCatherine J. Field Preclinical study 24 June 2019 Pages: 357 - 367
Combined inhibition of Aurora A and p21-activated kinase 1 as a new treatment strategy in breast cancer Vladislav KorobeynikovMichelle BorakoveElena Shagisultanova Preclinical study Open access 28 June 2019 Pages: 369 - 382
Iniparib administered weekly or twice-weekly in combination with gemcitabine/carboplatin in patients with metastatic triple-negative breast cancer: a phase II randomized open-label study with pharmacokinetics Véronique DiérasHervé BonnefoiJaap Verweij Clinical trial 06 June 2019 Pages: 383 - 393
Adherence to anti-estrogen therapy in women with hormone receptor-positive breast cancer utilizing bubble packaging: a pilot study Shruti BhandariPhuong NgoElizabeth C. Riley Clinical trial 06 June 2019 Pages: 395 - 399
Phase II study of irinotecan and temozolomide in breast cancer patients with progressing central nervous system disease Michelle E. MeliskoMichael AssefaHope S. Rugo Clinical trial 06 June 2019 Pages: 401 - 408
Clinical features of pseudocirrhosis in metastatic breast cancer Caspian OliaiMichael L. DouekSara A. Hurvitz Clinical trial 07 June 2019 Pages: 409 - 417
Preliminary results of computer-aided diagnosis for magnetic resonance imaging of solid breast lesions Qiujie YuKuan HuangWei Meng Clinical trial 15 June 2019 Pages: 419 - 426
Randomized controlled trial of high-dose versus standard-dose vitamin D3 for prevention of aromatase inhibitor-induced arthralgia Polly NiravathSusan G. HilsenbeckMothaffar F. Rimawi Clinical trial 19 June 2019 Pages: 427 - 435
Locoregional risk assessment after neoadjuvant chemotherapy in patients with primary breast cancer: clinical utility of the CPS + EG score Laura L. MichelLaura SommerFrederik Marmé Clinical trial 24 June 2019 Pages: 437 - 446
Detection of circulating tumor cells and circulating tumor DNA before and after mammographic breast compression in a cohort of breast cancer patients scheduled for neoadjuvant treatment Daniel FörnvikKristina E. AaltonenLisa Rydén Clinical trial Open access 24 June 2019 Pages: 447 - 455
Non-sentinel axillary tumor burden applying the ACOSOG Z0011 eligibility criteria to a large routine cohort Fabian RiedelJörg HeilAndré Hennigs Clinical trial 24 June 2019 Pages: 457 - 467
Do clinical trials truly mirror their target population? An external validity analysis of national register versus trial data from the Swedish prospective SENOMIC trial on sentinel node micrometastases in breast cancer Y. AnderssonL. BergkvistJ. de Boniface Clinical trial Open access 24 June 2019 Pages: 469 - 475
Effects of high-intensity interval training on vascular endothelial function and vascular wall thickness in breast cancer patients receiving anthracycline-based chemotherapy: a randomized pilot study Kyuwan LeeIrene KangChristina M. Dieli-Conwright Clinical trial 24 June 2019 Pages: 477 - 485
Severe acne and risk of breast cancer John D. MurphyDale SandlerKatie M. O’Brien Epidemiology 05 June 2019 Pages: 487 - 495
Treatment and survival of Asian women diagnosed with breast cancer in New Zealand Chunhuan LaoRoss LawrensonIan Campbell Epidemiology 05 June 2019 Pages: 497 - 505
Is core needle biopsy effective at diagnosing male breast lesions? Yinlong YangShiping LiZhiming Shao Epidemiology 05 June 2019 Pages: 507 - 511
Dietary intake from birth through adolescence in relation to risk of benign breast disease in young women Catherine S. BerkeyRulla M. TamimiGraham A. Colditz Epidemiology 20 June 2019 Pages: 513 - 525
Associations between mammographic density and tumor characteristics in Chinese women with breast cancer Erni LiJennifer L. GuidaXiaohong R. Yang Epidemiology 28 June 2019 Pages: 527 - 536
